The aim of this pilot study was to evaluate the bioactive, surface-coated polycaprolactone-co-lactide scaffolds as bone implants in a tibia critical size defect model. Polycaprolactone-co-lactide scaffolds were coated with collagen type I and chondroitin sulfate and 30 piled up polycaprolactone-co-lactide scaffolds were implanted into a 3 cm sheep tibia critical size defect for 3 or 12 months (n = 5 each). Bone healing was estimated by quantification of bone volume in the defects on computer tomography and microcomputer tomography scans, plain radiographs, biomechanical testing as well as by histological evaluations. New bone formation occurred at the proximal and distal ends of the tibia in both groups. The current pilot study revealed a mean new bone formation of 63% and 172% after 3 and 12 months, respectively. The bioactive, surface coated, highly porous three-dimensional polycaprolactone-co-lactide scaffold stack itself acted as a guide rail for new bone formation along and into the implant. These preliminary data are encouraging for future experiments with a larger group of animals.
CanceddaRGiannoniPMastrogiacomoM. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials2007; 28: 4240–4250.
2.
DrosseIVolkmerECapannaR. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury2008; 39: 9–20.
3.
JensenTJakobsenTBaasJ. Hydroxyapatite nanoparticles in poly-D,L-lactic acid coatings on porous titanium implants conducts bone formation. J Biomed Mater Res A2010; 95: 665–672.
4.
MihalkoWMHowardCDimaanoF. Effects of hydroxyapatite on titanium foam as a bone in growth surface in acetabular shells: a canine study. J Long Term Eff Med Implants2010; 20: 35–42.
5.
RammeltSHeckCBernhardtR. In vivo effects of coating loaded and unloaded Ti implants with collagen, chondroitin sulfate, and hydroxyapatite in the sheep tibia. J Orthop Res2007; 25: 1052–1061.
6.
ZhangPHongZYuT. In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(L-lactide). Biomaterials2009; 30: 58–70.
7.
BensaïdWOudinaKViateauV. De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng2005; 11: 814–824.
8.
SarkarMRAugatPShefelbineSJ. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials2006; 27: 1817–1823.
9.
ViateauVGuilleminGBoussonV. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res2007; 25: 741–749.
10.
BetzOBBetzVMAbdulazimA. The repair of critical-sized bone defects using expedited, autologous BMP-2 gene-activated fat implants. Tissue Eng Part A2010; 16: 1093–1101.
11.
BetzVMBetzOBGlattV. Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector dose. Hum Gene Ther2007; 18: 907–915.
12.
BlokhuisTJ. Formulations and delivery vehicles for bone morphogenetic proteins: latest advances and future directions. Injury2009; 40: 8–11.
13.
SchiekerMMutschlerW. Bridging posttraumatic bony defects: established and new methods. Unfallchirurg2006; 109: 715–732.
14.
Schmidt-RohlfingBTzioupisCMenzelCL. Tissue engineering of bone tissue: principles and clinical applications. Unfallchirurg2009; 112: 785–794.
15.
WilliamsJMAdewunmiASchekRM. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials2005; 26: 4817–4827.
16.
RentschCRentschBBreierA. Long-bone critical-size defects treated with tissue-engineered polycaprolactone-co-lactide scaffolds: a pilot study on rats. J Biomed Mater Res A2010; 95: 964–972.
17.
BramfeldtHSarazinPVermetteP. Chracterization, degradation, and mechanical strength of poly(D,L-lactide-co-ɛ-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-co-ɛ-caprolactone). J Biomed Mater Res A2007; 83: 503–511.
18.
TomihataKSuzukiMOkaT. A new resorbable monofilament suture. Polymer Degrad Stabil1998; 51: 13–18.
19.
RammeltSSchulzeEWittM. Collagen type I increases bone remodelling around hydroxyapatite implants in the rat tibia. Cells Tissues Organs2004; 178(3): 146–157.
20.
MorraMCassinelliCMedaL. Surface analysis and effects on interfacial bone microhardness of collagen-coated titanium implants: a rabbit model. Int J Oral Maxillofac Implants2005; 20(1): 23–30.
21.
RammeltSIllertTBierbaumS. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials2006; 27: 5561–5571.
22.
RentschBHofmannABreierA. Embroidered and surface modified polycaprolactone-co-lactide scaffolds as bioartificial bone substitute: in vitro characterization. Ann Biomed Eng2009; 37: 2118–2128.
23.
SchneidersWReinstorfABiewenerA. In vivo effects of modification of hydroxyapatite/collagen composites with and without chondroitin sulphate on bone remodeling in the sheep tibia. J Orthop Res2009; 27: 15–21.
24.
StadlingerBBierbaumSGrimmerS. Increased bone formation around coated implants. J Clin Periodontol2009; 36: 698–704.
25.
WollenweberMDomaschkeHHankeT. Mimicked bioartificial matrix containing chondroitin sulphate on a textile scaffold of poly(3-hydroxybutyrate) alters the differentiation of adult human mesenchymal stem cells. Tissue Eng2006; 12: 345–359.
26.
RentschCRentschBBreierA. Evaluation of the osteogenic potential and vascularization of 3D poly(3)hydroxybutyrate scaffolds subcutaneously implanted in nude rats. J Biomed Mater Res A2010; 92: 185–195.
27.
MasqueletAC. Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction. Langenbecks Arch Surg2003; 388(5): 344–346.
28.
BiewenerAMeyerJRentschC. Internal fixation of meta- and diaphyseal intercalary bone defects after tumour resection with intramedullary nailing and porous polymethylmetacrylate (PMMA) spacer. Orthopade2007; 36: 152–158, 160–163.
29.
NafeiADanielsenCCLindeF. Properties of growing trabecular ovine bone. Part I: mechanical and physical properties. J Bone Joint Surg Br2000; 82: 910–920.
30.
RegauerMJürgensIKotsianosD. New-bone formation by osteogenic protein-1 and autogenic bone marrow in a critical tibial defect model in sheep. Zentralbl Chir2005; 130: 338–345.
31.
ReichertJCEpariDRWullschlegerME. Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng Part B2010; 16: 93–104.
32.
HahnJAWitteTSArensD. Double-plating of ovine critical sized defects of the tibia: a low morbidity model enabling continuous in vivo monitoring of bone healing. BMC Musculoskelet Disord2011; 12: 214–214.
33.
AndersonMLDhertWJde BruijnJD. Critical size defect in the goat's os ilium: a model to evaluate bone grafts and substitutes. Clin Orthop Relat Res1999; 364: 231–239.
34.
ArinzehTLPeterSJArchambaultMP. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am2003; 85–A: 1927–1935.
35.
BruderSPKrausKHGoldbergVM. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am1998; 80: 985–996.
36.
KruytMCDhertWJYuanH. Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res2004; 22: 544–551.
37.
NiemeyerPFechnerKMilzS. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials2010; 31: 3572–3579.
38.
PetiteHViateauVBensaïdW. Tissue-engineered bone regeneration. Nat Biotechnol2000; 18: 959–963.
39.
ReichertJCWullschlegerMECipitriaA. Custom-made composite scaffolds for segmental defect repair in long bones. Int Orthop2011; 35(8): 1229–1236.
40.
MastrogiacomoMCorsiAFranciosoE. Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng2006; 12(5): 1261–1273.
41.
MittraERubinCQinYX. Mittra interrelationship of trabecular mechanical and microstructural properties in sheep trabecular bone. J Biomech2005; 38(6): 1229–1237.
42.
SchindelerAMcDonaldMMBokkoP. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol2008; 19: 459–466.
43.
HutmacherDWSchantzTZeinI. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res2001; 55(2): 203–216.
44.
WoodardJRHilldoreAJLanSK. The mechanical properties and osteoconductivity of hydroxyapatite bone scaffolds with multi-scale porosity. Biomaterials2007; 28(1): 45–54.
45.
RezwanKChenQZBlakerJJ. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials2006; 27(18): 3413–3431.
46.
LamCXSavalaniMMTeohSH. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions. Biomed Mater2008; 3(3): 034108–034108.
